170 related articles for article (PubMed ID: 28632724)
1. Oral squamous cell carcinoma patients can be differentiated from healthy individuals with label-free serum proteomics.
Saraswat M; Mäkitie A; Agarwal R; Joenväärä S; Renkonen S
Br J Cancer; 2017 Jul; 117(3):376-384. PubMed ID: 28632724
[TBL] [Abstract][Full Text] [Related]
2. Label-free tissue proteomics can classify oral squamous cell carcinoma from healthy tissue in a stage-specific manner.
Dickinson A; Saraswat M; Mäkitie A; Silén R; Hagström J; Haglund C; Joenväärä S; Silén S
Oral Oncol; 2018 Nov; 86():206-215. PubMed ID: 30409303
[TBL] [Abstract][Full Text] [Related]
3. Tongue Cancer Patients Can be Distinguished from Healthy Controls by Specific N-Glycopeptides Found in Serum.
Saraswat M; Mäkitie A; Tohmola T; Dickinson A; Saraswat S; Joenväärä S; Renkonen S
Proteomics Clin Appl; 2018 Nov; 12(6):e1800061. PubMed ID: 29992770
[TBL] [Abstract][Full Text] [Related]
4. Patients with early-stage oropharyngeal cancer can be identified with label-free serum proteomics.
Tuhkuri A; Saraswat M; Mäkitie A; Mattila P; Silén R; Dickinson A; Carpén T; Tohmola T; Joenväärä S; Renkonen S
Br J Cancer; 2018 Jul; 119(2):200-212. PubMed ID: 29961760
[TBL] [Abstract][Full Text] [Related]
5. Proteomics-based identification of haptoglobin as a novel plasma biomarker in oral squamous cell carcinoma.
Lai CH; Chang NW; Lin CF; Lin CD; Lin YJ; Wan L; Sheu JJ; Chen SY; Huang YP; Sing YT; Tao TW; Lai CK; Tsai MH; Chan HL; Jou YJ; Lin CW
Clin Chim Acta; 2010 Jul; 411(13-14):984-91. PubMed ID: 20359475
[TBL] [Abstract][Full Text] [Related]
6. Label-free plasma proteomics for the identification of the putative biomarkers of oral squamous cell carcinoma.
Gautam SS; Singh RP; Karsauliya K; Sonker AK; Reddy PJ; Mehrotra D; Gupta S; Singh S; Kumar R; Singh SP
J Proteomics; 2022 May; 259():104541. PubMed ID: 35231661
[TBL] [Abstract][Full Text] [Related]
7. Oral brush biopsy analysis by matrix assisted laser desorption/ionisation-time of flight mass spectrometry profiling--a pilot study.
Remmerbach TW; Maurer K; Janke S; Schellenberger W; Eschrich K; Bertolini J; Hofmann H; Rupf S
Oral Oncol; 2011 Apr; 47(4):278-81. PubMed ID: 21354855
[TBL] [Abstract][Full Text] [Related]
8. [Identification of serum biomarkers and evaluation of metabolism disorders in patients with oral squamous cell carcinoma].
Li XB; Liu LW; Li N; Jia QQ; Wang XS; Long JL; Xue P; Sun Z; Zhao HY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Sep; 56(9):926-932. PubMed ID: 34496544
[No Abstract] [Full Text] [Related]
9. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
[TBL] [Abstract][Full Text] [Related]
10. Discovery of potential serum protein biomarkers for lymph node metastasis in oral cancer.
Chai YD; Zhang L; Yang Y; Su T; Charugundla P; Ai J; Messadi D; Wong DT; Hu S
Head Neck; 2016 Jan; 38(1):118-25. PubMed ID: 25223295
[TBL] [Abstract][Full Text] [Related]
11. Proteomic diagnosis models from serum for early detection of oral squamous cell carcinoma.
Sun G; He H; Ping F; Zhang F
Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(3):125-9. PubMed ID: 19412825
[TBL] [Abstract][Full Text] [Related]
12. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
13. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Jiang T; Xie P; Liu H
J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
[TBL] [Abstract][Full Text] [Related]
14. Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.
Jiang T; Liu G; Wang L; Liu H
PLoS One; 2015; 10(7):e0133940. PubMed ID: 26207647
[TBL] [Abstract][Full Text] [Related]
15. S100A8 as potential salivary biomarker of oral squamous cell carcinoma using nanoLC-MS/MS.
Jou YJ; Hua CH; Lin CD; Lai CH; Huang SH; Tsai MH; Kao JY; Lin CW
Clin Chim Acta; 2014 Sep; 436():121-9. PubMed ID: 24863804
[TBL] [Abstract][Full Text] [Related]
16. Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers.
Csősz É; Lábiscsák P; Kalló G; Márkus B; Emri M; Szabó A; Tar I; Tőzsér J; Kiss C; Márton I
PLoS One; 2017; 12(5):e0177282. PubMed ID: 28545132
[TBL] [Abstract][Full Text] [Related]
17. [Proteomics study of the serum biomarkers in tongue cancer].
Huang X; Kang FW; Li LJ; Wen YM
Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Sep; 42(9):550-2. PubMed ID: 18070433
[TBL] [Abstract][Full Text] [Related]
18. miR-186, miR-3651 and miR-494: potential biomarkers for oral squamous cell carcinoma extracted from whole blood.
Ries J; Vairaktaris E; Agaimy A; Kintopp R; Baran C; Neukam FW; Nkenke E
Oncol Rep; 2014 Mar; 31(3):1429-36. PubMed ID: 24452363
[TBL] [Abstract][Full Text] [Related]
19. Oral squamous cell carcinoma: Key clinical questions, biomarker discovery, and the role of proteomics.
Malik UU; Zarina S; Pennington SR
Arch Oral Biol; 2016 Mar; 63():53-65. PubMed ID: 26691574
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miRNA-424: a sign of field cancerisation in clinically normal tongue adjacent to squamous cell carcinoma.
Boldrup L; Coates PJ; Laurell G; Wilms T; Fahraeus R; Nylander K
Br J Cancer; 2015 May; 112(11):1760-5. PubMed ID: 25965165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
